U.S. Molecular Diagnostics Markets

 

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

The study provides a U.S. market scenario for molecular diagnostics markets. The markets are divided as Infectious diseases, cancer, and pharmacogenomics markets. Emerging markets in molecular diagnostics are also discussed. Product analysis and technology analysis are detailed in the study. The study provides competitive position of key market participants. Frost & Sullivan awards are bestowed to well deserving companies in the industry.

Table of Contents

U.S. Molecular Diagnostics Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Molecular Diagnostics Markets, Total MarketOverviewIntroductionResearch MethodologyMarket ForecastsOverviewMarket Segment OverviewRevenue ForecastsCompetitive LandscapeMarket Share AnalysisProduct AnalysisChallenges and StrategiesIndustry ChallengesStrategic RecommendationsFrost & Sullivan AwardsProduct Innovation AwardTechnology Innovation AwardTechnology Leadership AwardProduct Launch Strategy AwardU.S. Molecular Diagnostics Markets, Infectious Diseases MarketsOverviewIntroductionMarket Engineering AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket ForecastsRevenue ForecastsCompetitive LandscapeDemand and Product AnalysisMarket Share AnalysisMarket and Technology TrendsCompetitive StructureEmerging Markets - West Nile VirusIntroductionMarket PotentialDiagnostic SolutionsU.S. Molecular Diagnostics Markets, Cancer Diagnostics MarketsOverviewIntroductionMarket Engineering AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket ForecastsRevenue ForecastsCompetitive LandscapeDemand AnalysisProduct and Pricing AnalysisMarket Share AnalysisTechnology TrendsCompetitive StructureU.S. Molecular Diagnostics Markets, Pharmacogenomics MarketsOverviewIntroductionMarket Engineering AnalysisMarket DynamicsMarket DriversMarket RestraintsMarket ForecastsRevenue ForecastsCompetitive LandscapeDemand AnalysisProduct and Pricing AnalysisMarket Share AnalysisKey Market ParticipantsCompetitive StructureEmerging Markets - HCV GenotypingIntroductionDiagnostic Solutions and Market PotentialU.S. Molecular Diagnostics Markets, AppendixDecision Support DatabasesBiotechnology CompaniesBreast Cancer IncidenceProstate Cancer IncidenceLung Cancer IncidenceLiver Cancer IncidenceColon Rectal Cancer Incidence




Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.